May 14, 2025 9:00am EDT Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
Apr 15, 2025 8:30am EDT Dermata’s XYNGARI(TM) Phase 3 Trial Hits Statistically Significant Difference at 4 Weeks
